Difference between revisions of "Team:Marburg/Results"

Line 285: Line 285:
 
                     created
 
                     created
 
                     a
 
                     a
                     lvl 0 part of the Cas12a protein by amplifying the sequence from the pSL2680 plasmid, including
+
                     lvl0 part of the Cas12a protein by amplifying the sequence from the pSL2680 plasmid, including
 
                     overhangs
 
                     overhangs
 
                     that
 
                     that
Line 301: Line 301:
 
                     1
 
                     1
 
                     constructs
 
                     constructs
                     - which we promptly did, using the following lvl 0 parts:
+
                     - which we promptly did, using the following lvl0 parts:
 
                     pMC0_1_03 + pMC0_2_03 + pMC0_3_07 + pMC0_4_33 + pMC0_5_07 + pMC0_6_17. </p>
 
                     pMC0_1_03 + pMC0_2_03 + pMC0_3_07 + pMC0_4_33 + pMC0_5_07 + pMC0_6_17. </p>
 
                     <figure Style="text-align:center">
 
                     <figure Style="text-align:center">
Line 980: Line 980:
 
               <p>We built and validated 55 new BioBricks this year. They are all listed in the Registry of Standard
 
               <p>We built and validated 55 new BioBricks this year. They are all listed in the Registry of Standard
 
                 Biological Parts
 
                 Biological Parts
                 (Part range BBa_3228000 to BBa_32280103). All LVL 0 Parts were validated by complete sequencing.<br>
+
                 (Part range BBa_3228000 to BBa_32280103). All lvl0 Parts were validated by complete sequencing.<br>
  
 
                 <figure style="text-align:center">
 
                 <figure style="text-align:center">
Line 1,012: Line 1,012:
 
                 toxicity in a genomic context (source things where genome parts can be exchanged by integrating such
 
                 toxicity in a genomic context (source things where genome parts can be exchanged by integrating such
 
                 sequences) we built
 
                 sequences) we built
                 it into an integration vector. For sequencing results see the dropdown menu below.
+
                 it into an integration vector.
 
               </p><br><br>
 
               </p><br><br>
 
               <p><u>Sequencing results of the lvl1 parts for modularized genome integrations</u></p>
 
               <p><u>Sequencing results of the lvl1 parts for modularized genome integrations</u></p>
Line 1,041: Line 1,041:
 
               </p><br> <br>
 
               </p><br> <br>
 
               <p><u>Workflow to integrate a modularized integration cassette</u></p>
 
               <p><u>Workflow to integrate a modularized integration cassette</u></p>
               <p>We established a workflow on how to integrate a cassette - from LVL 0 Parts to a finished change in
+
               <p>We established a workflow on how to integrate a cassette - from lvl0 Parts to a finished change in
 
                 genome. With
 
                 genome. With
                 UTEX 2973 this is possible in less than five days, while in PCC the same integration would take a
+
                 UTEX 2973 this is possible in less than five days, while in PCC7942 the same integration would take a
 
                 whole
 
                 whole
 
                 month.</p><br>
 
                 month.</p><br>
Line 1,053: Line 1,053:
 
                   alt="anso wirkflow">
 
                   alt="anso wirkflow">
 
                 <figcaption style="max-width: 2400px; text-align: center">
 
                 <figcaption style="max-width: 2400px; text-align: center">
                   Fig.11: Workflow of integration
+
                   Fig.11: Workflow for finding new neutral integration sites.
 
                 </figcaption>
 
                 </figcaption>
 
               </figure><br><br>
 
               </figure><br><br>
Line 1,282: Line 1,282:
 
                               </tr>
 
                               </tr>
 
                               <tr>
 
                               <tr>
                                 <th>LVL 1 Golden Gate Assembly</th>
+
                                 <th>lvl1 Golden Gate Assembly</th>
 
                                 <td>
 
                                 <td>
  
Line 1,455: Line 1,455:
 
                               </tr>
 
                               </tr>
 
                               <tr>
 
                               <tr>
                                 <th><b>LVL 1 Golden Gate mix for measurement vector assembly</b></th>
+
                                 <th><b>lvl1 Golden Gate mix for measurement vector assembly</b></th>
 
                                 <td>
 
                                 <td>
  
Line 1,611: Line 1,611:
 
                               </tr>
 
                               </tr>
 
                               <tr>
 
                               <tr>
                                 <th><b>LVL 1 Golden Gate mix for inserting the promoter</b>></th>
+
                                 <th><b>lvl1 Golden Gate mix for inserting the promoter</b>></th>
 
                                 <td>
 
                                 <td>
  
Line 1,755: Line 1,755:
 
                               </tr>
 
                               </tr>
 
                               <tr>
 
                               <tr>
                                 <th><b>LVL 1 Golden Gate mix for measurement vector assembly</b></th>
+
                                 <th><b>lvl1 Golden Gate mix for measurement vector assembly</b></th>
 
                                 <td>
 
                                 <td>
  

Revision as of 18:22, 8 December 2019

R E S U L T S


The way to the results we demonstrate here was full of success and failure. Therefore, it was necessary to compare and revise our theoretical plans with the practical work and the associated results. After trying our best to implement our plans, we would like to show you on this page that we have managed to realize some of our goals and are able to show some achievements for every sub-group.


S T R A I N
E N G I N E E R I N G


By genetic modification of S. elongatus UTEX 2973 we succeeded the transformation of plasmids in UTEX 2973.

M A R B U R G
C O L L E C T I O N  2.0


We expanded the Marburg Collection by adding the Green expansion and the first MoClo compatible shuttle vector for Cyanobacteria.